Development of small-diameter vascular prostheses which release bioactive agents

Burkel, 1982, Biocompatibility of prosthetic graft, 221 Green, 1979, A comparison of rapid-healing prosthetic arterial graft and autogeneous vein, Arch. Surg., 114, 944, 10.1001/archsurg.1979.01370320076014 Sauvage, 1974, Future direction in the development of arterial prostheses for small and. medium caliber arteries, Surg. Clin. North Am., 54, 213, 10.1016/S0039-6109(16)40245-8 Yates, 1973, Surface thrombogenicity of arterial prostheses, Surg. Gynecol. Obstet., 136, 12 Van Kampen, 1979, Effect of implant surface chemistry upon arterial thrombosis, J. Biomed. Mater. Res., 13, 517, 10.1002/jbm.820130402 Jayakumary, 1985, Blood-material interaction, Biomater. Med. Dev. Artif. Organs, 12, 97, 10.3109/10731198409118827 Pitt, 1986, Sequential protein adsorption and thrombus deposition on polymeric biomaterials, J. Colloid Interface Sci., 111, 343, 10.1016/0021-9797(86)90039-1 Lelah, 1986 Lyman, 1978, Compliance as a factor effecting the patency of a copolyurethane vascular graft, Journal of Biomedical Material Research, 12, 337, 10.1002/jbm.820120307 Seifert, 1979, Effect of elasticity of prosthetic wall on patency of smalldiameter arterial prostheses, Surg. Forum., 30, 206 Abbot, 1982, Control of physical characteristics (elasticity and compliance) of vascular grafts, 131 Clark, 1976, Mismatch of mechanical properties as a cause of arterial prostheses thrombosis, Surg. Forum., 27, 208 Pellock, 1981, Tissue ingrowth and porosity of Biomer, Trans. Am. Soc. Artif. Inter. Organs, 27, 405 Goldberg, 1981, Effect of surface porosity on early thrombogenicity using vascular grafts with two surfaces in sequence, Trans. Am. Soc. Artif. Inter. Organs, 27, 517 Rudeman, 1972, A partially biodegradable vascular prosthesis, Trans. Am. Soc. Artif. Intern. Organs, 18, 30, 10.1097/00002480-197201000-00009 Bowald, 1980, Absorbable material in vascular prostheses. A new device, Acta Chir. Scand., 146, 391 Matlaga, 1983, Ultrastructural observations of cells at the interface of a biodegradable polymer Polyglactin 910, Journal of Biomedical Material Research, 17, 185, 10.1002/jbm.820170115 Greisler, 1985, Arterial regenerative activity after prosthetic implantation, Arch. Surg., 120, 315, 10.1001/archsurg.1985.01390270055010 van der Lei, 1985, Regeneration of the arterial wall in microporous, com pliant, biodegradable vascular grafts after implantation into the rat abdominal aorta, Cell. Tissue Res., 242, 569, 10.1007/BF00225423 D'Amore, 1986, Growth factors, angiogenesis and metastasis, Cancer Metastasis: Experimental and Clinical Strategies, 212, 269 Maciag, 1979, An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization, 76, 5674 Burgess, 1986, Structural evidence that endothelial cell growth factor β is the precursor of both endothelial cell growth factor and acidic fibroblast growth factor, 83, 72116 Burgess, 1985, Multiple forms of endothelial cell growth factor, J. Biol. Chem., 260, 11389, 10.1016/S0021-9258(17)39038-5 Maciag, 1984, Factors which stimulate the growth of human umbilical vein endothelial cells in vitro, 87 Thomas, 1984, Purification and characterization of acidic fibroblast growth factor from bovine brain, 81, 357 Gospodarowicz, 1978, Purification of the fibroblast growth factor activity from bovine brain, J. Biol. Chem., 253, 3736, 10.1016/S0021-9258(17)34863-9 D'Amore, 1981, Angiogenic activity from bovine retina: Partial purification and characterization, 78, 3068 Baird, 1985, Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor, Biochem. Biophys. Res. Commun., 126, 358, 10.1016/0006-291X(85)90614-X Klagsbrun, 1985, Heparin affinity of anionic and cationic capillary endothelial cell growth factors: Analysis of hypothalamus-derived growth factor and fibroblast growth factors, 82, 805 Gospodarowicz, 1984, Isolation of brain fibroblast growth factor by heparin-Seppharose affinity chromatography: Identity with pituitary fibroblast growth factor, 81, 6963 Sullivan, 1985, Purification of cartilage derived growth factor by heparin affinity chromatography, J. Biol. Chem., 260, 2399, 10.1016/S0021-9258(18)89567-9 Hauschika, 1986, Growth in bone matrix, J. Biol. Chem., 261, 12665 Shing, 1984, Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor, Science, 223, 1296, 10.1126/science.6199844 Klagsbrun, 1986, Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor, 83, 2448 Greisler, 1987, Biomaterial pretreatment with ECGF to augment endothelial cell proliferation, J. Vasc. Surg., 2, 393, 10.1016/0741-5214(87)90151-0 Brown, 1983, In vivo and in vitro release of macromolecules from polymeric drug delivery systems, J. of Pharm. Sci., 72, 1181, 10.1002/jps.2600721019 Rhine, 1980, Polymers for sustained macromolecule release: Procedures to fabricate reproducible delivery systems and control release kinetics, J. of Pharm. Sci., 69, 265, 10.1002/jps.2600690305 Gospodarowicz, 1979, The angiogenic activity of the fibroblast and epidermal growth factor, Exp. Eye Res., 28, 501, 10.1016/0014-4835(79)90038-1 Soldani, G., Panol, G., Goddard, H. F. & Galletti, P. M., Small-diameter polyurethane-polydimethylsiloxane vascular prostheses made by a spraying, phase inversion process. J. Mater. Sci.—Mat. in Med. (in press). Soldani, 1991, Bioartificial polymeric materials obtained from blends of synthetic polymers with fibrin, and collagen, J. Artif. Org., 14, 295, 10.1177/039139889101400510 Jaffe, 1973, Culture of human endothelial cells derived from umbilical veins, J. Clan. Invest., 52, 2745, 10.1172/JCI107470 Murray, 1983, A micro sustained release system for epidermal growth factor, In Vitro, 19, 743, 10.1007/BF02618093 Kesting, 1985